You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Immune thrombocytopenia

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Primary Immune Thrombocytopenia

Recruiting
  • Immune Thrombocytopenia
  • ITP
    • Beijing, Beijing, China
      Peking University Insititute of Hematology, Peking University Pe
    Jan 24, 2022

    Primary Immune Thrombocytopenia (ITP) Trial in Switzerland (Eltrombopag (Revolade®), standard therapy (without eltrombopag):

    Recruiting
    • Primary Immune Thrombocytopenia (ITP)
    • Eltrombopag (Revolade®)
    • standard therapy (without eltrombopag): HD-DXM
    • Aarau, Switzerland
    • +5 more
    Sep 5, 2022

    Primary Immune Thrombocytopenia Trial in Ukraine (Intravenous immunoglobulin (IVIG), 10% solution for infusion)

    Recruiting
    • Primary Immune Thrombocytopenia
    • Intravenous immunoglobulin (IVIG), 10% solution for infusion
    • Kropyvnytskyi, Ukraine
    • +5 more
    Aug 9, 2022

    Immune Thrombocytopenia Trial in Japan (Avatrombopag Oral Tablet)

    Recruiting
    • Immune Thrombocytopenia
    • Avatrombopag Oral Tablet
    • Toyohashi, Aichi, Japan
    • +18 more
    Jan 11, 2023

    Primary Immune Thrombocytopenia Trial in Beijing (STSA-1301 subcutaneous injection, Placebo)

    Recruiting
    • Primary Immune Thrombocytopenia
    • STSA-1301 subcutaneous injection
    • Placebo
    • Beijing, Chaoyang District, China
      Beijing Ditan Hospital,Capital Medical University
    Nov 28, 2023

    Primary Immune Thrombocytopenia (ITP) Trial in Tianjin (TPO-RAs, TPO-RAs combining anti-CD 20 mAb)

    Not yet recruiting
    • Primary Immune Thrombocytopenia (ITP)
    • TPO-RAs
    • TPO-RAs combining anti-CD 20 monoclonal antibody
    • Tianjin, China
      Institute of Hematology and Blood Diseases Hospital, Chinese Aca
    Feb 7, 2023

    Primary Immune Thrombocytopenia Trial in Worldwide (Rozanolixizumab)

    Completed
    • Primary Immune Thrombocytopenia
    • Boston, Massachusetts
    • +26 more
    Jan 16, 2023

    Functional Activity of Platelets for Differential Diagnosis of

    Not yet recruiting
    • Immune Thrombocytopenia
    • +3 more
    • Flow cytometry
    • Platelet aggregation and plasma coagulation
    • (no location specified)
    Dec 8, 2022

    Healthy, Primary Immune Thrombocytopenia, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Trial in Worldwide

    Recruiting
    • Healthy
    • +2 more
    • PF-06755347 intravenous healthy participant
    • +4 more
    • New Haven, Connecticut
    • +5 more
    Dec 29, 2022

    Immune Thrombocytopenia (ITP) Trial in Worldwide (BIVV020)

    Active, not recruiting
    • Immune Thrombocytopenia (ITP)
    • Washington, District of Columbia
    • +8 more
    May 3, 2022

    Immune Thrombocytopenia Trial in Beijing (Orelabrutinib)

    Not yet recruiting
    • Immune Thrombocytopenia
    • Beijing, Beijing, China
      Peking University Institute of Hematology
    Nov 6, 2021

    Some Cytokines Expression in ITP Primary Immune Thrombocytopenic

    Recruiting
    • Primary Immune Thrombocytopenia
    • Plasma RNA isolation, qPCR analysis of micro RNA
    • +2 more
    • Sohag, Egypt
      Sohag University
    May 7, 2022

    Risk Factors for Thrombosis in Immune Thrombocytopenia

    Completed
    • Immune Thrombocytopenia
      • Toulouse, France
        University Hospital Toulouse
      Sep 3, 2021

      Thrombocytopenia Trial (Chidamide, HD-DXM)

      Not yet recruiting
      • Thrombocytopenia
      • (no location specified)
      Jun 6, 2022

      Immune Status Before and After Splenectomy in Immune

      Recruiting
      • Thrombocytopenia
      • Splenectomy
      • splenectomy
      • Tianjin, Tianjin, China
        Yunfei Chen
      Aug 25, 2021

      Purpura, Thrombocytopenic, Idiopathic Trial in Germany, United Kingdom, United States (BIVV009 6.5 grams, BIVV009 7.5 grams)

      Completed
      • Purpura, Thrombocytopenic, Idiopathic
      • BIVV009 6.5 grams
      • BIVV009 7.5 grams
      • Georgetown, District of Columbia
      • +4 more
      Apr 22, 2022

      Primary Immune Thrombocytopenia Trial in Worldwide (PF-06835375)

      Suspended
      • Primary Immune Thrombocytopenia
      • PF-06835375
      • Jacksonville, Florida
      • +27 more
      Jan 25, 2023

      Chronic Immune Thrombocytopenia Trial in United States (Panzyga)

      Recruiting
      • Chronic Immune Thrombocytopenia
      • Panzyga
      • Sacramento, California
      • +7 more
      Dec 6, 2021

      Immune Thrombocytopenia Trial in United States (Eltrombopag, Steroids, IVIG)

      Recruiting
      • Immune Thrombocytopenia
      • Birmingham, Alabama
      • +26 more
      Dec 12, 2022

      Immune Thrombocytopenia (ITP) Trial (Neofordex®, Intravenous immunoglobulins)

      Not yet recruiting
      • Immune Thrombocytopenia (ITP)
      • (no location specified)
      Nov 22, 2021

      Immune Thrombocytopenia (ITP) Trial (HMPL-523, Placebo)

      Not yet recruiting
      • Immune Thrombocytopenia (ITP)
      • (no location specified)
      Aug 25, 2021

      Immune Thrombocytopenia Trial in Beijing (Dexamethasone, ATRA)

      Completed
      • Immune Thrombocytopenia
      • Beijing, Beijing, China
        Peking University Insititute of Hematology, Peking University Pe
      Sep 22, 2021

      Immune Thrombocytopenia, Autoantibodies, Evan Syndrome Trial in Tianjin (Avatrombopag)

      Recruiting
      • Immune Thrombocytopenia
      • +3 more
      • Tianjin, Tianjin, China
        Institute of Hematology & Blood Diseases Hospital
      Aug 3, 2021

      Role of Fcgamma Receptors in Immune Thrombocytopenia (ITP)

      Recruiting
      • Immune Thrombocytopenia
      • blood sample
      • spleen sample
      • Dijon, France
        CHU Dijon Bourgogne
      Jun 18, 2021

      Primary Immune Thrombocytopenia(ITP)

      Recruiting
      • Primary Immune Thrombocytopenia
      • Jinan, Shandong, China
        Qilu Hospital, Shandong University
      Jun 24, 2021